Publicacions en què col·labora amb FRANCISCO JAVIER ARIAS VALLEJO (9)

2023

  1. CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer

    Biomaterials Advances, Vol. 154

2021

  1. Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation

    International Journal of Pharmaceutics, Vol. 599

2016

  1. Anti-Human endoglin (hCD105) immunotoxin— Containing recombinant single chain ribosome- Inactivating protein musarmin 1

    Toxins, Vol. 8, Núm. 6

2004

  1. Bacterial expression of biologically active recombinant musarmin 1 from bulbs of Muscari armeniacum L. and Miller

    Journal of Biotechnology, Vol. 112, Núm. 3, pp. 313-322

2003

  1. Isolation and characterization of a new D-galactose-binding lectin from Sambucus racemosa L.

    Protein and Peptide Letters, Vol. 10, Núm. 3, pp. 287-293

  2. Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 49, Núm. 4, pp. 537-545

  3. cDNA molecular cloning and seasonal acumulation of an ebulin l-related dimeric lectin of dwarf elder (Sambucus ebulus L.) leaves

    International Journal of Biochemistry and Cell Biology, Vol. 35, Núm. 7, pp. 1061-1065

1995

  1. A new procedure for the preparation of highly active melonin from the dry seeds of Cucumis melo L.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 41, Núm. 2, pp. 279-287

1993

  1. Molecular mechanism of inhibition of mammalian protein synthesis by some four-chain agglutinins. Proposal of an extended classification of plant ribosome-inactivating proteins (rRNA N-glycosidases)

    FEBS Letters, Vol. 329, Núm. 1-2, pp. 59-62